Cancer cells - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Atreca doses first patient in Phase Ib trial of oncology drug

Cancer cells
More than 50% of tumour tissue samples evaluated in various cancer types were positive for the antigenic target of ATRC-101. Credit: skeeze from Pixabay.